3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Breast
1
Conditions
Neoplasms
3
Non-small Cell Lung Cancer Metastatic
2
Non-squamous Non-small-cell Lung Cancer (NSQ NSCLC)
1
Non-squamous Non-small Cell Lung Cancer
1
Breast Cancer Metastatic
1
Adenocarcinoma Gastric
1
Interventions
Trastuzumab
3
Docetaxel
3
Gemcitabine
2
tusamitamab ravtansine
1
nirogacestat
1
margetuximab
1
exemestane
1
Vinorelbine
1
Tamoxifen
1
Letrozole
1
Fulvestrant
1
Capecitabine
1
Anastrozole
1
Ado-Trastuzumab Emtansine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Breast Cancer Metastatic
×
tusamitamab ravtansine
×
Clear all
NCT04659603
2025-10-01
CARMEN-BT01
Sanofi
Phase 2
Terminated
50 enrolled
20 charts